CHICAGO and GAINESVILLE, Fla., April 12, 2011 (GLOBE NEWSWIRE) -- Avery Dennison Medical Solutions, a division of Avery Dennison Corporation (NYSE:AVY) and a global leader in pressure-sensitive adhesive technologies for medical applications, in partnership with Quick-Med Technologies, Inc. (OTCQB:QMDT), a life sciences company that develops innovative technologies for healthcare and consumer markets, today announced the completion of a license agreement for Quick-Med’s NIMBUS® technology. The announcement comes after Avery Dennison Medical Solutions’ successful development of a new antimicrobial adhesive featuring NIMBUS technology that can be incorporated into a variety of medical device applications, including surgical, wound care and vascular access products. The antimicrobial adhesive can be effective across multiple organisms even in the presence of large amounts of serum and body fluids.
